FR2952382B1 - Vaccins et diagnostics contre les trypanosomoses animales africaines - Google Patents

Vaccins et diagnostics contre les trypanosomoses animales africaines

Info

Publication number
FR2952382B1
FR2952382B1 FR0957953A FR0957953A FR2952382B1 FR 2952382 B1 FR2952382 B1 FR 2952382B1 FR 0957953 A FR0957953 A FR 0957953A FR 0957953 A FR0957953 A FR 0957953A FR 2952382 B1 FR2952382 B1 FR 2952382B1
Authority
FR
France
Prior art keywords
trypanosomoses
diagnoses
vaccines
against african
african animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0957953A
Other languages
English (en)
Other versions
FR2952382A1 (fr
Inventor
Linares Virginie Coustou
Theo Baltz
Nicolas Plazolles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Bordeaux Segalen
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0957953A priority Critical patent/FR2952382B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2 filed Critical Centre National de la Recherche Scientifique CNRS
Priority to MX2012005406A priority patent/MX2012005406A/es
Priority to AU2010317992A priority patent/AU2010317992A1/en
Priority to AP2012006303A priority patent/AP2012006303A0/xx
Priority to PCT/EP2010/067245 priority patent/WO2011058080A1/fr
Priority to EP10782574A priority patent/EP2499244A1/fr
Priority to CA2779076A priority patent/CA2779076A1/fr
Priority to BR112012011009A priority patent/BR112012011009A2/pt
Priority to CN2010800509473A priority patent/CN102858963A/zh
Priority to US13/508,851 priority patent/US20120276131A1/en
Publication of FR2952382A1 publication Critical patent/FR2952382A1/fr
Application granted granted Critical
Publication of FR2952382B1 publication Critical patent/FR2952382B1/fr
Priority to CO12076206A priority patent/CO6551741A2/es
Priority to CO12076211A priority patent/CO6551742A2/es
Priority to ZA2012/03412A priority patent/ZA201203412B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
FR0957953A 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines Expired - Fee Related FR2952382B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0957953A FR2952382B1 (fr) 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines
BR112012011009A BR112012011009A2 (pt) 2009-11-10 2010-11-10 vacinas contra tripanossomíase e diagnóstico
AP2012006303A AP2012006303A0 (en) 2009-11-10 2010-11-10 Anti-trypanosomiasis vaccines and diagnostics.
PCT/EP2010/067245 WO2011058080A1 (fr) 2009-11-10 2010-11-10 Vaccins et diagnostics contre les trypanosomoses
EP10782574A EP2499244A1 (fr) 2009-11-10 2010-11-10 Vaccins et diagnostics contre les trypanosomoses
CA2779076A CA2779076A1 (fr) 2009-11-10 2010-11-10 Vaccins et diagnostics contre les trypanosomoses
MX2012005406A MX2012005406A (es) 2009-11-10 2010-11-10 Vacunas y diagnosticos contra la tripanosomosis.
CN2010800509473A CN102858963A (zh) 2009-11-10 2010-11-10 锥虫病疫苗和诊断
US13/508,851 US20120276131A1 (en) 2009-11-10 2010-11-10 Anti-trypanosomiasis vaccines and diagnostics
AU2010317992A AU2010317992A1 (en) 2009-11-10 2010-11-10 Anti-trypanosomiasis vaccines and diagnostics
CO12076206A CO6551741A2 (es) 2009-11-10 2012-05-09 Vacunas y diagnóstico contra la tripanosomosis
CO12076211A CO6551742A2 (es) 2009-11-10 2012-05-09 Aplicaciones terapèuticas y de diagnóstico contra tripanosomosis
ZA2012/03412A ZA201203412B (en) 2009-11-10 2012-05-10 Anti-trypanosomiasis vaccines and diagnostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0957953A FR2952382B1 (fr) 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines

Publications (2)

Publication Number Publication Date
FR2952382A1 FR2952382A1 (fr) 2011-05-13
FR2952382B1 true FR2952382B1 (fr) 2011-11-25

Family

ID=42170832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0957953A Expired - Fee Related FR2952382B1 (fr) 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines

Country Status (12)

Country Link
US (1) US20120276131A1 (fr)
EP (1) EP2499244A1 (fr)
CN (1) CN102858963A (fr)
AP (1) AP2012006303A0 (fr)
AU (1) AU2010317992A1 (fr)
BR (1) BR112012011009A2 (fr)
CA (1) CA2779076A1 (fr)
CO (2) CO6551742A2 (fr)
FR (1) FR2952382B1 (fr)
MX (1) MX2012005406A (fr)
WO (1) WO2011058080A1 (fr)
ZA (1) ZA201203412B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153153A1 (fr) * 2013-03-14 2014-09-25 Tufts University Compositions et procédés pour le traitement de maladies inflammatoires
WO2014167112A1 (fr) * 2013-04-12 2014-10-16 Danmarks Tekniske Universitet Sialidase mutante ayant une activité de trans-sialidase destinée à être utilisée en production de glycanes sialylés
CN103278642A (zh) * 2013-05-15 2013-09-04 广西大学 一种检测伊氏锥虫vsg抗原的双抗体夹心酶联免疫吸附测定试剂盒及制备方法
US10821164B2 (en) * 2015-06-23 2020-11-03 Saint Louis University Peptides for inducing Chagas disease responses
RU2686695C1 (ru) * 2017-11-27 2019-04-30 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени Я.Р. Коваленко" (ФГБНУ ВИЭВ) Способ дифференциальной диагностики случной болезни (t. equiperdum) и сурры (t. evansi) лошадей

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958035A (fr) 1950-03-02
US6027934A (en) * 1994-04-29 2000-02-22 Powell; Curtis Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
MA25182A1 (fr) * 1996-03-12 2001-07-02 Sovarec Sa Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn vecteur, organisme hote, tests et vaccins correspondants et leur utilisation
WO2002019960A2 (fr) 2000-09-06 2002-03-14 Pays, Etienne Purification, caracterisation et utilisation de structures antigeniques protectrices contre des trypanosomes et des parasites apparentes
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
BRPI0709560A2 (pt) 2006-03-17 2011-07-19 Vib Vzw uso de uma proteìna mutante de trans-sialidade de trypanosoma enzimaticamente inativa, e composição farmacêutica
EP2152301A4 (fr) 2007-04-28 2010-07-28 Fraunhofer Usa Inc Antigènes de trypanosome, compositions de vaccins et procédés associés

Also Published As

Publication number Publication date
CO6551742A2 (es) 2012-10-31
AP2012006303A0 (en) 2012-06-30
AU2010317992A1 (en) 2012-06-21
MX2012005406A (es) 2013-02-27
CN102858963A (zh) 2013-01-02
CO6551741A2 (es) 2012-10-31
BR112012011009A2 (pt) 2016-11-29
EP2499244A1 (fr) 2012-09-19
FR2952382A1 (fr) 2011-05-13
US20120276131A1 (en) 2012-11-01
CA2779076A1 (fr) 2011-05-19
ZA201203412B (en) 2013-07-31
WO2011058080A1 (fr) 2011-05-19

Similar Documents

Publication Publication Date Title
IL254600A0 (en) pcsk9 vaccine
DK2490940T3 (da) Uav-system og fremgangsmåde
ZA201204050B (en) Vaccination syringe
DK2415771T3 (da) Indolizinderivat og anvendelse deraf til medicinske formål
BR112012001637A2 (pt) dispositivo médico implantável
IL217008A0 (en) Vaccine
EP2406288A4 (fr) Vaccins ciblés vers des cellules présentant des antigènes
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
BRPI1008270A2 (pt) aparelho e sistema
BR112012000032A2 (pt) meios terapêuticos e diagnósticos inovadores
EP2408473A4 (fr) Procédés de vaccination
ZA201201714B (en) Protein matrix vaccines of improved immunogenicity
GB201006165D0 (en) Vaccine
BRPI1007909A2 (pt) método e dispositivo médico
EP2320943A4 (fr) Vaccins pour le bétail
FR2952382B1 (fr) Vaccins et diagnostics contre les trypanosomoses animales africaines
GB201000522D0 (en) Vaccine
FR2952649B1 (fr) Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines
EP2411039A4 (fr) Vaccins glycoconjugués
GB0808780D0 (en) Fish vaccines
IL217194A0 (en) Vaccine
EP2461679A4 (fr) Stabilisant pour vaccin
GB0913102D0 (en) Animal models and therapeutic molesules
IT1394241B1 (it) Fodera per materasso e metodo per realizzarla.
TH129806B (th) วัคซีนพิษแบคทีเรีย

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -, FR

Effective date: 20110822

Owner name: UNIVERSITE BORDEAUX SEGALEN, FR

Effective date: 20110822

ST Notification of lapse

Effective date: 20140731